Clinical trials

It is important to remember that every drug available in pharmacies has been evaluated in clinical trials.

Atopic dermatitis

Atopic dermatitis is a chronic allergic disease manifested by inflammation of the skin. If you are suffering from atopic dermatitis, contact us! We will contact you as soon as possible, in order to guarantee the possibility of participation in this study. We hope it will come soon!

Study title: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study evaluating the efficacy, safety and tolerability of NCT03761537 in combination with topical corticosteroids in adult patients with severe atopic dermatitis.

Therapeutic area: dermatology, atopic dermatitis

Sponsor Name: LEO Pharma

Test start date: December 28, 2018

End date: May 2020

source: www.clinicaltrials.gov

Study title: A multicentre, double-trial study to evaluate the long-term safety and efficacy of NCT03334435 (baricitinib) in adult patients with atopic dermatitis.

Therapeutic area: dermatology, atopic dermatitis

Sponsor Name: Eli Lilly and Company

Test start date: March 28, 2018

End date: August 27, 2021

source: www.clinicaltrials.gov

Study title: multicenter, double-blind, randomized, placebo-controlled. Study evaluating the safety and efficacy of NCT03428100 (baricitinib) in combination with topical corticosteroids in adult patients with moderate to severe atopic dermatitis.

Therapeutic area: dermatology, atopic dermatitis

Sponsor Name: Eli Lilly and Company

Test start date: May 15, 2018

End date: May 15, 2021

source: www.clinicaltrials.gov

Other Clinical Trials

Check what tests we are currently conducting in our facility.

Contact form

for patients

What kind of contact from our site you prefer:
Telephone conversation - please mark Consent I + Consent III
E-mail, sms - please mark Consent I + Consent III
Close Menu
en_GBEnglish (UK)
pl_PLPolski en_GBEnglish (UK)

Personal Data Protection Personal data protection

We have a personal data protection policy in accordance with the GDPR. This site uses cookies to provide services at the highest level. By continuing to use the site, you agree to their use.

Personal Data Administrator is Centrum Badań Klinicznych PI-House Sp. z o. o with its registered office in Gdańsk (80-546), ul. Na Zaspa 3, registered in the Gdańsk-Północ District Court in Gdańsk, VII Commercial Department of the National Court Register under the number KRS: 0000394618, NIP: 9571059089.

Please be advised that the Data Administrator has appointed a Personal Data Protection Inspector. You have the right to contact the Data Protection Officer directly using the email address: iod@pihouse.pl.

Learn more by clicking this link

We run a policy of personal data protection according to ROPE.
Our website uses cookies to improve your experience. By continuing to browse our website, you are agreeing to our use of cookies.
The administrator of Personal Data is the Centrum Badań Klinicznych PI-House Sp. z o. o. with headquarters in Gdańsk (80-546), ul. Na Zaspa 3, registered at the District Court Gdańsk - Północ in Gdańsk, VII Commercial Division of the National Court Register under KRS number: 0000394618, Taxpayer identification number: 9571059089.
Please be advised that the Data Administrator has appointed the Data Protection Inspector. You have the right to contact the Data Protection Supervisor using the e-mail address: iod@pihouse.pl.
Learn more by clicking this link

Basic information
Ladies and Gentlemen, answering the questions contained in the survey below will allow us to choose the right diagnostic and medical consultation proposal for you. Participation in our free research programs is completely voluntary.
Please list all medications you are currently taking along with the doses:
I consent to the processing of my personal data, including sensitive data, based on the GDPR Art. 6 point a. in order to protect my health, provide medical services to me and conduct medical clinical trials by the Centrum Badań Klinicznych PI-House sp. z o.o. with headquarters in Gdańsk, ul. Na Zaspa 3. Consent to the processing of my personal data also includes consent to their processing in the future, provided that the purpose of processing does not change. I have been informed about the right to view and correct data and to obtain information on the data collected. At the same time, I agree to the use of my data, including sensitive data, to: inform me about the possibility of participating in free preventive examinations, assessing the possibility of qualifying me for clinical tests and inviting me to participate in such examination. I agree to receive information about the offer of preventive tests or clinical tests and about upcoming visits to the PI-House Clinical Research Center with the use of means of distance communication in the form of telephone contact, email, sms or written notification addressed to the address I provided. I consent to the processing of my data for the purposes and scope indicated in this consent in IT systems.